Bruce W. Bode

26.9k total citations · 7 hit papers
242 papers, 14.6k citations indexed

About

Bruce W. Bode is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Bruce W. Bode has authored 242 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Endocrinology, Diabetes and Metabolism, 122 papers in Surgery and 69 papers in Genetics. Recurrent topics in Bruce W. Bode's work include Diabetes Management and Research (212 papers), Diabetes Treatment and Management (121 papers) and Pancreatic function and diabetes (121 papers). Bruce W. Bode is often cited by papers focused on Diabetes Management and Research (212 papers), Diabetes Treatment and Management (121 papers) and Pancreatic function and diabetes (121 papers). Bruce W. Bode collaborates with scholars based in United States, Denmark and United Kingdom. Bruce W. Bode's co-authors include Paul C. Davidson, R. Dennis Steed, Timothy S. Bailey, Satish K. Garg, Richard M. Bergenstal, Irl B. Hirsch, Robert E. Ratner, Alan J. Garber, Mark P. Christiansen and Andrew Lewin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Bruce W. Bode

236 papers receiving 13.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

2008 882 citations Bruce W. Bode et al. profile →
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes

2015 793 citations Melanie J. Davies, Richard M. Bergenstal et al. profile →
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System

2015 519 citations Timothy S. Bailey, Bruce W. Bode et al. Diabetes Technology & Therapeutics profile →
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

2020 503 citations Bruce W. Bode, Valerie Garrett et al. Journal of Diabetes Science and Technology profile →
Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia

2013 428 citations Richard M. Bergenstal, Satish K. Garg et al. profile →
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

2017 415 citations Satish K. Garg, Bruce A. Buckingham et al. Diabetes Technology & Therapeutics profile →
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus

2021 179 citations Jennifer L. Sherr, Bruce W. Bode et al. Endocrine Practice profile →

Peers

Countries citing papers authored by Bruce W. Bode

Since Specialization

Citations

This map shows the geographic impact of Bruce W. Bode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce W. Bode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce W. Bode more than expected).

Fields of papers citing papers by Bruce W. Bode

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce W. Bode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce W. Bode. The network helps show where Bruce W. Bode may publish in the future.

Co-authorship network of co-authors of Bruce W. Bode

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce W. Bode. A scholar is included among the top collaborators of Bruce W. Bode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce W. Bode. Bruce W. Bode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhaled insulin in pregnancy: A case series supporting feasibility and clinical potential for pregnant people with diabetes 2025 ·SHILAP Revista de lepidopterología ·(unknown), Linda A. Barbour, Bruce W. Bode, (unknown), (unknown), (unknown), Amy M. Valent	1
2	Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range 2023 ·Diabetes Therapy ·Timothy S. Bailey, Bruce W. Bode, Qianqian Wang, (unknown), Annette M. Chang	4
3	Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers 2023 ·Pediatric Diabetes ·Korey K. Hood, William H. Polonsky, Sarah A. MacLeish, Carol J. Levy, Gregory P. Forlenza, Amy Criego, Bruce A. Buckingham, Bruce W. Bode, David W. Hansen, Jennifer L. Sherr, Sue A. Brown, Daniel J. DeSalvo, Sanjeev N. Mehta, Lori M. Laffel, Anuj Bhargava, Lauren M. Huyett, Todd Vienneau, Trang T. Ly	6
4	Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) 2023 ·Annals of Internal Medicine ·Harpreet S. Bajaj, Jens Aberle, Melanie J. Davies, Anders Meller Donatsky, Marie Frederiksen, Di̇lek Gogas Yavuz, Amoolya Gowda, Ildiko Lingvay, Bruce W. Bode	57
5	Accuracy of Three Commercial Home-Use Hemoglobin A1c Tests 2022 ·Diabetes Technology & Therapeutics ·Laura M. Jacobsen, Laura E. Bocchino, John W. Lum, Craig Kollman, (unknown), (unknown), Michael J. Haller, Bruce W. Bode, (unknown), Anthony A. Killeen, Uttam Garg, David R. Liljenquist, Janey Adams, (unknown), Deanna Gabrielson, (unknown), Mark A. Clements, Roy W. Beck	4
6	Ultrarapid Lispro Demonstrates Similar Time in Target Range to Lispro with a Hybrid Closed-Loop System 2021 ·Diabetes Technology & Therapeutics ·Bruce W. Bode, Anders L. Carlson, Rong Liu, Thomas A. Hardy, Richard M. Bergenstal, Jennifer Boyd, (unknown), (unknown)	26
7	An Evaluation of Two Capillary Sample Collection Kits for Laboratory Measurement of HbA1c 2021 ·Diabetes Technology & Therapeutics ·Roy W. Beck, Laura E. Bocchino, John W. Lum, Craig Kollman, (unknown), (unknown), Michael J. Haller, Bruce W. Bode, (unknown), Anthony A. Killeen, Uttam Garg, David R. Liljenquist, Janey Adams, (unknown), Deanna Gabrielson, (unknown), Mark A. Clements	33
8	Clinical Evaluation of a Novel CGM-Informed Bolus Calculator with Automatic Glucose Trend Adjustment 2021 ·Diabetes Technology & Therapeutics ·Jordan E. Pinsker, Mei Mei Church, Sue A. Brown, Mary Voelmle, Bruce W. Bode, (unknown), Lauren M. Huyett, Joon Bok Lee, (unknown), Eric Benjamin, Bonnie Dumais, Trang T. Ly	6
9	70-OR: Evaluation of the Omnipod 5 Automated Insulin Delivery System in Very Young Children with Type 1 Diabetes (T1D) 2021 ·Diabetes ·Jennifer L. Sherr, Bruce W. Bode, Gregory P. Forlenza, Lori M. Laffel, Sue A. Brown, Bruce A. Buckingham, Amy Criego, Daniel J. DeSalvo, Sarah A. MacLeish, David W. Hansen, Trang T. Ly	1
10	Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States breakdown → 2020 ·Journal of Diabetes Science and Technology ·Bruce W. Bode, Valerie Garrett, Jordan Messler, Raymie McFarland, Jennifer Crowe, Robby Booth, David C. Klonoff	503
11	Glycemic responses to strenuous training in male professional cyclists with type 1 diabetes: a prospective observational study 2020 ·BMJ Open Diabetes Research & Care ·(unknown), Max L. Eckstein, Sam N. Scott, Federico Y. Fontana, Mark P. Christiansen, Christoph Stettler, Miles Fisher, Bruce W. Bode, Michael C. Riddell, Charlotte Hayes, (unknown), Phil Southerland, Othmar Moser, Richard M. Bracken	15
12	Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial 2019 ·Diabetes Care ·Bruce W. Bode, Violeta Iotova, М. А. Коваренко, Lori M. Laffel, Paturi Vishnupriya Rao, Srikanth Deenadayalan, Magnus Ekelund, (unknown), Thomas Danne	46
13	Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes 2019 ·Diabetes Care ·David C. Klonoff, Bruce W. Bode, Nathan Cohen, Marc S. Penn, (unknown), Douglas B. Muchmore	19
14	Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study 2018 ·Diabetes Care ·John B. Buse, Satish K. Garg, Julio Rosenstock, Timothy S. Bailey, Phillip Banks, Bruce W. Bode, Thomas Danne, Jake A. Kushner, Wendy Lane, Pablo Lapuerta, Darren K. McGuire, Anne L. Peters, John H. Reed, Sangeeta Sawhney, Paul Strumph	172
15	Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study 2018 ·Diabetes Technology & Therapeutics ·Halis Kaan Aktürk, Janet K. Snell‐Bergeon, (unknown), Leslie J. Klaff, Bruce W. Bode, Anne L. Peters, Timothy S. Bailey, Satish K. Garg	40
16	Improved Time-in-Range (TIR) on Continuous Glucose Monitor (CGM) with Technosphere Inhaled Insulin (TI) Compared with Insulin Aspart in T1D Patients—STAT Study 2018 ·Diabetes ·Janet K. Snell‐Bergeon, Halis Kaan Aktürk, (unknown), Bruce W. Bode, Leslie J. Klaff, Anne L. Peters, Timothy S. Bailey, Satish K. Garg	1
17	Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes 2018 ·Diabetes Technology & Therapeutics ·Gregory P. Forlenza, Orit Pinhas‐Hamiel, David R. Liljenquist, Dorothy I. Shulman, Timothy S. Bailey, Bruce W. Bode, Michael A. Wood, Bruce A. Buckingham, Kevin B. Kaiserman, John Shin, Suiying Huang, Scott W. Lee, Francine Kaufman	138
18	Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study 2015 ·Diabetes Technology & Therapeutics ·Ram Weiss, Satish K. Garg, Bruce W. Bode, Timothy S. Bailey, Andrew Ahmann, (unknown), John Welsh, John Shin, (unknown)	43
19	Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial 2011 ·Diabetes Technology & Therapeutics ·Arianne C. van Bon, Bruce W. Bode, (unknown), J. Hans DeVries, G. Charpentier	74
20	Switch to Multiple Daily Injections with Insulin Glargine and Insulin Lispro From Continuous Subcutaneous Insulin Infusion With Insulin Lispro: A Randomized, Open-Label Study Using A Continuous Glucose Monitoring System 2005 ·Endocrine Practice ·Bruce W. Bode, R. Dennis Steed, (unknown), Poul Strange	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact